EVARF — Lombard Medical Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Lombard Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS/A | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.17 | 6.96 | 13.3 | 15.1 | 12.2 |
| Cost of Revenue | |||||
| Gross Profit | 2.22 | 2.65 | 5.74 | 6.82 | 1.14 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 19.3 | 27 | 49.4 | 54.4 | 41 |
| Operating Profit | -13.1 | -20 | -36.1 | -39.3 | -28.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.7 | -20.3 | -36 | -40 | -32.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.2 | -19.2 | -34.8 | -37.8 | -31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.2 | -19.2 | -34.8 | -37.8 | -31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -13.2 | -19.2 | -34.8 | -37.8 | -31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.888 | -1.3 | -2.32 | -2.13 | -1.43 |
| Dividends per Share |